A COMPARATIVE STUDY OF SEROLOGICAL FINDINGS OF NT PRO BNP LEVELS IN HIGHLY HYDRATED I.E. ORALLY HYDRATED (BEFORE INVESTIGATION) IN POST COVID 19 PATIENTS OF MILD, MODERATE, SEVERE CATEGORY.
Keywords:
NT pro BNP, COVID-19, SARS-CoV-2, Biomarker, Post covid patientAbstract
Coronavirus disease (COVID-19) is an infectious disease caused by the SARSCoV-2 virus. Most people infected with the virus experience mild to moderate
respiratory illness and recover without requiring special treatment. However, some
become seriously ill and require medical attention. Brain natriuretic peptide (BNP)
and N-terminal proBNP (NT-proBNP) are normally only found in blood in trace
levels. High levels could be a sign that the heart isn't pumping blood as effectively
as it ought to. NT‐proBNP is frequently elevated in COVID‐19. It is strongly and
independently associated with mortality. Therefore, its use may improve early
prognostic stratification in this condition. A study measuring the NT pro BNP
serum levels in 36 individuals across three groups of 12 participants each was
conducted in post Covid Patients of mild, moderate and severe category.
The attempt was made to create temporary tolerable hypervolumia to create
temporary cardiovascular stress by means of overhydration of participants by
maximum oral consumption of water at a time point. The temporarily generated
over hydration/ hypervolumia of the participants was utilized to create the
artificially conditioned stimuli to activate neurological/endocrinological gut-brain
axis. It was observed that out of 36 participants of three groups, only 2 patients
serological NT pro BNP value was higher than normal. On the basis of the data
obtained in the present study, it is found that there is association of severity of
COVID-19 disease and serological NT pro BNP values.
Serological level of NT pro BNP plays role in pathophysiology of COVID 19
disease. Further study should be done on larger sample size to focus on NT Pro
BNP levels
References
Role of B‐type natriuretic peptide (BNP) and NT‐proBNP in clinical routine
-By Michael Weber et al. Heart. Free PMC article: 2006 Jun 21
The role of biomarkers in diagnosis of COVID-19 – A systematic review -
Muhammed Kermali, Raveena Kaur Khalsa, [...], and Amer Harky: 2020
April 28
NTproBNP: an important biomarker in cardiac diseases Vasiliki
Panagopoulou 1, SpyridonDeftereos, CharalamposKossyvakis, Konstantinos
Raisakis, Georgios Giannopoulos, Georgios Bouras, Vlasios
Pyrgakis, Michael W Cleman- Affiliations expand PMID: 23470072 DOI:
2174/1568026611313020002
4.Coronavirus disease (COVID-19): a scoping review – By Meng Lv, Xufei
Luo,Janne Estill : 2020 Apr 16; 25(15): 2000125.
Prevalence and predictive value of anemia and dysregulated iron homeostasis
in patients with COVID-19 Infection. J Clin Med. - - - Bellmann-Weiler R,
Lanser L, Barket R, Rangger L, Schapfl A, Schaber Metal. (2020) 9:E2429.
doi: 10.3390/jcm9082429
Hematological findings and complications of COVID-19. Terpos E, NtanasisStathopoulos I, Elalamy I, Kastritis E, Sergentanis TN, Politou M, et al Amer
J Hematol. (2020) 95:834–47. doi: 10.1002/ajh25829
Lymphopenia predicts disease severity of COVID-19: a descriptive and
predictive study. Signal Transduct Target Ther. ---- Tan L, Wang Q, Zhang D,
Ding J, Huang Q, Tang YQ, et al. (2020) 5:33. doi: 10.1038/s41392 -020-
-4
Decreased T cell populations contribute to the increased severity of COVID -
- Liu R, Wang Y, Li J, Han H, Xia Z, Liu F, et al. Clin Chim Acta. (2020)
:110–4. doi: 10.1016/j.cca.2020.05019
Selective CD8 cell reduction by SARS-CoV-2 is associated with a worse
prognosis and systemic inflammation in COVID-19 patients. - Urra JM,
Cabrera CM, Porras L, Ródenas I Clin Immunol. (2020) 217:108486.
doi: 10.1016/j.clim.2020108486
lymphocytes for predicting the clinical progression of patients with COVID19. - Hou H, Zhang B, Huang H, Luo Y, Wu S, Tang G, et al. Using IL-2R/
Clin Exp Immunol. (2020) 201:76–84. doi: 10.1111/cei13450
Procalcitonin in patients with severe coronavirus disease 2019 (COVID-19):
A meta-analysis. - Lippi G, Plebani M Clin Chim Acta. (2020) 505:190–1.
doi: 10.1016/j.cca.2020.03004
Serum ferritin as a predictor of the acute respiratory distress syndrome. -
Connelly KG, Moss M, Parsons PE, Moore EE, Moore FA, Giclas PC, et al.
Am J Respir Crit Care Med. 1997;155: 21–25. pmid:9001283
Mild versus severe COVID-19: Laboratory markers. International Journal of
Infectious Diseases. -Velavan TP, Meyer CG. 2020;95: 304–307.
pmid:32344011
A Comparative Study Of Serological Findings Of NT PRO BNP Levels In Highly
Hydrated I.E. Orally Hydrated (Before Investigation) In Post Covid 19 Patients
Of Mild, Moderate, Severe Category
ISSN:1517-4492 | E-ISSN:2178-7727 308 © 2024 Authors
Vol. 7, No. 1 (2024)
Characterization of NT‐proBNP in a large cohort of COVID‐19 patients [220]
Juan Caro-Codón et al. Eur J Heart Fail..Free PMC article
Authors: Juan Caro-Codón 1, Juan R Rey 1, Antonio Buño 2, Angel M Iniesta 1,
Sandra O Rosillo 1, Sergio Castrejon-Castrejon 1, Laura Rodriguez-Sotelo 1,
Luis A Martinez 1, Irene Marco 1, Carlos Merino 1, Lorena Martin-Polo 1, Jose
M Garcia-Veas 1, Marcel Martinez-Cossiani 1, Luis Gonzalez-Valle 3, Alicia
Herrero 3, Esteban López-de-Sa 1, Jose L Merino 1 - 2021 Mar;23(3): 456-
doi: 10.1002/ejhf.2095
N-terminal pro-B-type natriuretic peptide as a prognostic test for ventricular
dysfunction in patients with coronary disease: data from the heart and soul
study. Archives of internal medicine. - Corteville DC, bibbins-Domingo K, Wu
AH, Ali S, Schiller NB, Whooley MA. 2007 Mar 12;167(5):483-9